Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma

被引:16
|
作者
Fleming, S. [1 ]
Cooper, R. A. [2 ]
Swift, S. E. [1 ]
Thygesen, H. H. [3 ]
Chowdhury, F. U. [1 ,4 ]
Scarsbrook, A. F. [1 ,4 ]
Patel, C. N. [1 ,4 ]
机构
[1] St James Univ Hosp, Dept Clin Radiol, Leeds LS9 7TF, W Yorkshire, England
[2] St James Univ Hosp, Dept Clin Oncol, Leeds LS9 7TF, W Yorkshire, England
[3] St James Univ Hosp, Leeds Canc Res UK Ctr, Leeds LS9 7TF, W Yorkshire, England
[4] St James Univ Hosp, Dept Nucl Med, Leeds LS9 7TF, W Yorkshire, England
关键词
POSITRON-EMISSION-TOMOGRAPHY; CANCER PATIENTS; CHEMORADIOTHERAPY; RADIOTHERAPY; SURVIVAL; PATTERNS; FAILURE;
D O I
10.1016/j.crad.2014.07.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To evaluate the impact of staging FDG PET-CT on the initial management of patients with locally advanced cervical carcinoma (LACC) and any prognostic variables predicting survival. MATERIALS AND METHODS: Retrospective analysis of consecutive patients undergoing FDG PET-CT for staging of LACC in a single tertiary referral centre, between April 2008 and August 2011. Comparison was made between MRI and PET-CT findings and any subsequent impact on treatment intent or radiotherapy planning was evaluated. RESULTS: Sixty-three patients underwent FDG PET-CT for initial staging of LACC. Major impact on management was found in 20 patients (32%), a minor impact in five (8%), and no impact in 38 (60%). In those patients where PET-CT had a major impact, 12 had more extensive local nodal involvement, five had occult metastatic disease, two had synchronous tumours, and one patient had equivocal lymph nodes on MRI characterized as negative. PET-positive nodal status at diagnosis was found to be a statistically significant predictor of relapse-free survival (p < 0.05). CONCLUSION: Staging FDG PET-CT has a major impact on the initial management of approximately one-third of patients with LACC by altering treatment intent and/or radiotherapy planning. PET-defined nodal status is a poor prognostic indicator. (C) 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1235 / 1243
页数:9
相关论文
共 50 条
  • [41] Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy
    Scarsbrook, Andrew
    Vaidyanathan, Sriram
    Chowdhury, Fahmid
    Swift, Sarah
    Cooper, Rachel
    Patel, Chirag
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) : 581 - 588
  • [42] 18F-FDG PET/CT in locally advanced cervical cancer: A review
    Caresia-Aroztegui, A. P.
    Delgado-Bolton, R. C.
    Alvarez-Ruiz, S.
    Del Puig Cozar-Santiago, M.
    Orcajo-Rincon, J.
    de Arcocha-Torres, M.
    Garcia-Velloso, M. J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 59 - 68
  • [43] Initial Nodal Staging of Locally Advanced Cervical Cancer with FDG-PET/CT
    Caresia Aroztegui, A. P.
    Barahona Orpinell, M.
    Sabria Bach, E.
    Gamez Cenzano, C.
    Cortes Romera, M.
    Sanchez Marquez, A.
    Robles Barba, J.
    Rodriguez Bel, L.
    Rossi Seoane, S.
    Marti Cardona, L.
    Ponce i Sebastia, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S579 - S579
  • [44] Clinical Outcomes of Definitive IMRT with FDG-PET Simulation in Patients with Locally Advanced Cervical Cancer
    Kidd, E. A.
    Siegel, B. A.
    Dehdashti, F.
    Rader, J. S.
    Mutic, S.
    Mutch, D. G.
    Powell, M. A.
    Grigsby, P. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S357 - S358
  • [45] The impact of FDG PET/CT on the management of Merkel cell carcinoma
    Sayer, C.
    Westwell, S.
    Raman, V.
    Burkill, G.
    Dizdarovic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S376 - S376
  • [46] Role of FDG PET-CT in HTT treatment planning for patients with locally advanced pancreatic cancer: selection and treatment monitoring
    Picchio, M.
    Giovannini, E.
    Landoni, C.
    Passoni, P.
    Crivellaro, C.
    Reni, M.
    Bettinardi, V.
    Di Muzio, N.
    Gilardi, M. C.
    Gianolli, L.
    Messa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S223 - S223
  • [47] Clinical relevance of the use of FDG PET/CT in locally advanced breast cancer
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Koolen, Bas
    Rutgers, Emiel J.
    Rodenhuis, Sjoerd
    Olmos, Renato O. Valdes
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [48] Predictive Value of 18F-FDG-PET/CT in Locally Advanced Cervical Carcinoma Treated with Neoadjuvant Chemotherapy
    Ippolito, M.
    Cosentino, S.
    Sara, B.
    Gabriella, M.
    Franco, M.
    Scibilia, G.
    Banna, G.
    Fraggetta, F.
    Parisi, A.
    Lipari, H.
    Scollo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S495 - S495
  • [49] F-18 FDG PET-CT in identifying distant metastatic disease in patients with locally advanced breast cancer
    Manohar, K.
    Kashyap, R.
    Kamaleshwaran, K. K.
    Bhattacharya, A.
    Singh, B.
    Mittal, B. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S247 - S247
  • [50] The Role of the Metabolic Parameters of 18F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
    Wang, Dunhuang
    Liu, Xiaoliang
    Wang, Weiping
    Huo, Li
    Pan, Qingqing
    Ren, Xue
    Zhang, Fuquan
    Hu, Ke
    FRONTIERS IN ONCOLOGY, 2021, 11